PAG
ARKG icon

Private Advisor Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Private Advisor Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,600
Closed -$9K – 1894
2020
Q4 		$9K Buy
+1,600
New +$127K ﹤0.01% 1763

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CFIM
Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
SFC
Strategic Financial Concepts San Antonio, Texas $336M AUM 22.98% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Private Advisor Group's ARKG Position: Q2 2026 in Review

Private Advisor Group increased its ARK Genomic Revolution ETF (ARKG) stake by 88% in Q2 2026, buying an estimated $596K and bringing the position to 39,844 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #1101.

Private Advisor Group first reported a position in ARKG in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.9M in Q1 2021. 94 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Private Advisor Group held 39,844 shares of ARK Genomic Revolution ETF worth $1.68M as of Q2 2026.
  • Private Advisor Group bought 18,700 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $596K.
  • ARK Genomic Revolution ETF made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1101 holding.
  • Private Advisor Group first reported a position in ARK Genomic Revolution ETF in Q3 2018 and has held it in 32 quarters since.
  • Private Advisor Group's ARK Genomic Revolution ETF position peaked at $10.9M in Q1 2021.
  • 94 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.